Development of many critically important pharmaceuticals, existing and yet to come, grows out of macromolecular x-ray crystallography-based research carried out at sources of high-brightness x-rays such as the U.S. Department of Energy Office of Science’s Advanced Photon Source at Argonne National Laboratory and the APS Upgrade, which will open new vistas in drug discovery.